Summary slide.png (122.37 kB)

A Multicenter, Retrospective Study (RE-ENACT 2) on RazumabTM (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion

Download (122.37 kB)
figure
posted on 19.06.2020 by Shashikant Sharma, RE-ENACT 2 Study Investigators Group, Mujtaba Khan, Alok Chaturvedi

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020

History

Exports